在trimethoprim和pyrimethamine之间的Plasmodium falciparum交叉耐药性之间
Lancet (London, England)
|October 9, 2001
概括
用于艾滋病毒/艾滋病治疗的trimethoprim-sulfamethoxazole可能会降低sulfadoxine-pyrimethamine的有效性,这是一个关键的抗疟疾药物. 需要紧急评估,以探索交叉耐药性和替代治疗方法.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 三甲-硫甲是非洲的标准艾滋病毒/艾滋病治疗方法.
- 硫素-甲胺是艾滋病毒发病率高的地区的一线抗疟药.
研究的目的:
- 为了调查TMP和pyrimethamine之间的潜在交叉耐药性.
- 评估TMP-SMX对艾滋病毒感染个体的SP疗效的影响.
主要方法:
- 对Plasmodium falciparum耐药机制的分子水平分析.
- 审查当前的治疗指南和药物疗效数据.
主要成果:
- 在Plasmodium falciparum中证实了trimethoprim和pyrimethamine之间的分子交叉耐药性.
- 在接受trimethoprim-sulfamethoxazole的患者中,硫黄素-皮里美胺的有效性可能会降低.
结论:
- 需要紧急评估TMP-SMX对SP疗效的影响.
- 对于接受TMP-SMX预防的个体,应考虑使用替代性抗疟疾策略.
相关概念视频
Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Diversity of Protists II
Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...


